Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C.

Lancet. 2012 Aug 11;380(9841):581-90. doi: 10.1016/S0140-6736(12)60367-5. Epub 2012 May 17.

2.

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.

Cholesterol Treatment Trialists' (CTT) Collaboration, Emberson JR, Kearney PM, Blackwell L, Newman C, Reith C, Bhala N, Holland L, Peto R, Keech A, Collins R, Simes J, Baigent C.

PLoS One. 2012;7(1):e29849. doi: 10.1371/journal.pone.0029849. Epub 2012 Jan 19.

3.

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R.

Lancet. 2010 Nov 13;376(9753):1670-81. doi: 10.1016/S0140-6736(10)61350-5. Epub 2010 Nov 8.

5.

Planned, ongoing and recently completed clinical trials for atherosclerosis prevention and regression: an update.

Mellies M, McGovern M.

Expert Opin Investig Drugs. 1997 Jan;6(1):31-50.

PMID:
15989560
6.

Effects of one year of treatment with pravastatin, an HMG-CoA reductase inhibitor, on lipoprotein a.

Hunninghake DB, Stein EA, Mellies MJ.

J Clin Pharmacol. 1993 Jun;33(6):574-80.

PMID:
8366183
7.

Pravastatin experience in elderly and non-elderly patients.

Mellies MJ, DeVault AR, Kassler-Taub K, McGovern ME, Pan HY.

Atherosclerosis. 1993 Jun;101(1):97-110. Erratum in: Atherosclerosis 1993 Sep;102(2):231.

PMID:
8216507
8.

Long-term experience with pravastatin in clinical research trials.

McGovern ME, Mellies MJ.

Clin Ther. 1993 Jan-Feb;15(1):57-64. Review.

PMID:
8458055
9.

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing.

Hunninghake DB, Mellies MJ, Goldberg AC, Kuo PT, Kostis JB, Schrott HG, Insull W Jr, Pan HY.

Atherosclerosis. 1990 Dec;85(2-3):219-27.

PMID:
2129319
10.

Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study.

Hunninghake DB, Knopp RH, Schonfeld G, Goldberg AC, Brown WV, Schaefer EJ, Margolis S, Dobs AS, Mellies MJ, Insull W Jr, et al.

Atherosclerosis. 1990 Nov;85(1):81-9.

PMID:
2126437
11.

Fenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind, placebo-controlled multicenter US study.

Goldberg AC, Schonfeld G, Feldman EB, Ginsberg HN, Hunninghake DB, Insull W Jr, Knopp RH, Kwiterovich PO, Mellies MJ, Pickering J, et al.

Clin Ther. 1989;11(1):69-83.

PMID:
2655907
12.

Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia.

Knopp RH, Brown WV, Dujovne CA, Farquhar JW, Feldman EB, Goldberg AC, Grundy SM, Lasser NL, Mellies MJ, Palmer RH, et al.

Am J Med. 1987 Nov 27;83(5B):50-9.

PMID:
3318454
13.

Dr. Glueck and co-authors' letter of withdrawal.

Glueck CJ, Laskarzewski P, Mellies MJ, Perry T.

Pediatrics. 1987 Nov;80(5):766. No abstract available.

PMID:
3313259
14.

Effects of fenofibrate on lipids, lipoproteins, and apolipoproteins in 33 subjects with primary hypercholesterolemia.

Mellies MJ, Stein EA, Khoury P, Lamkin G, Glueck CJ.

Atherosclerosis. 1987 Jan;63(1):57-64.

PMID:
3548734
15.

Effects of fenofibrate on plasma lipids. Double-blind, multicenter study in patients with type IIA or IIB hyperlipidemia.

Brown WV, Dujovne CA, Farquhar JW, Feldman EB, Grundy SM, Knopp RH, Lasser NL, Mellies MJ, Palmer RH, Samuel P, et al.

Arteriosclerosis. 1986 Nov-Dec;6(6):670-8.

17.

The Effects of Physical Training on Blood Lipid Profiles in Adolescents With Insulin-Dependent Diabetes Mellitus.

Campaigne BN, Landt KW, Mellies MJ, James FW, Glueck CJ, Sperling MA.

Phys Sportsmed. 1985 Dec;13(12):83-9. doi: 10.1080/00913847.1985.11708949.

PMID:
27421157
18.
19.

The substitution of sucrose polyester for dietary fat in obese, hypercholesterolemic outpatients.

Mellies MJ, Vitale C, Jandacek RJ, Lamkin GE, Glueck CJ.

Am J Clin Nutr. 1985 Jan;41(1):1-12.

PMID:
3966411
20.

Cincinnati Lipid Research Clinic.

Glueck CJ, Laskarzewski PM, Morrison JA, Khoury P, Kelly K, Mellies MJ, Rao DC.

Prog Clin Biol Res. 1984;147:149-54.

PMID:
6610876
Items per page

Supplemental Content

Loading ...
Write to the Help Desk